tiprankstipranks
Trending News
More News >
Pharming Group Nv (PHAR)
:PHAR
US Market
Advertisement

Pharming Group (PHAR) Technical Analysis

Compare
160 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Pharming Group Nv’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting Pharming Group Nv is a Buy.
Pharming Group Nv’s (PHAR) 20-Day exponential moving average is 14.12, while Pharming Group Nv’s (PHAR) share price is $14.21, making it a Sell.
Pharming Group Nv’s (PHAR) 50-Day exponential moving average is 13.83, while Pharming Group Nv’s (PHAR) share price is $14.21, making it a Sell.

Pharming Group (PHAR) Pivot Points

Oct 29, 2025, 01:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.30
12.82
13.07
13.59
13.84
14.36
14.61
Fibonacci
12.82
13.11
13.29
13.59
13.88
14.06
14.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Oct 29, 2025, 01:30 PM
Period
Simple
Exponential
MA5
13.72Buy
13.74Buy
MA10
13.91Sell
13.91Sell
MA20
14.42Sell
14.12Sell
MA50
14.28Sell
13.83Sell
MA100
12.61Buy
12.85Buy
MA200
10.82Buy
11.33Buy
Pharming Group Nv’s (PHAR) 10-Day exponential moving average is 13.91, while Pharming Group Nv’s (PHAR) share price is $14.21, making it a Sell.
Pharming Group Nv’s (PHAR) 100-Day exponential moving average is 12.85, while Pharming Group Nv’s (PHAR) share price is $14.21, making it a Buy.
Pharming Group Nv’s (PHAR) stock price is $14.21 and Pharming Group Nv’s (PHAR) 50-day simple moving average is 14.28, creating a Sell signal.
Pharming Group Nv’s (PHAR) stock price is $14.21 and Pharming Group Nv’s (PHAR) 100-day simple moving average is 12.61, creating a Buy signal.
Pharming Group Nv’s (PHAR) stock price is $14.21 and Pharming Group Nv’s (PHAR) 200-day simple moving average is 10.82, creating a Buy signal.

Pharming Group (PHAR) Technical Indicators

Oct 29, 2025, 01:30 PM
Name
Value
Implied Action
RSI (14)
47.20
Neutral
STOCH (9,6)
27.94
Neutral
STOCHRSI (14)
25.55
Neutral
MACD (12,26)
-0.17
Buy
ADX (14)
12.55
Buy
Williams %R
-60.69
Buy
CCI (14)
-103.06
Buy
ATR (14)
0.81
-
Ultimate Oscillator
48.86
Neutral
ROC
-4.24
Sell
Pharming Group Nv’s (PHAR) Relative Strength Index (RSI) is 47.20, creating a Neutral signal.
Pharming Group Nv’s (PHAR) Trend Strength Indicator (ADX) is 12.55, creating a Buy signal.
Pharming Group Nv’s (PHAR) Commodity Channel Index (CCI) is -103.06, creating a Buy signal.
Pharming Group Nv’s (PHAR) Price Rate of Change (ROC) is -4.24, creating a Sell signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Hold.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 47.20, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is -0.17, which suggests PHAR is a Buy.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 13.72, which suggests PHAR is a Buy.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 14.42, which suggests PHAR is a Sell.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 14.28, which suggests PHAR is a Sell.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 10.82, which suggests PHAR is a Buy.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -60.69, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is -103.06, which suggests PHAR is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis